Tardive Dyskinesia Quiz

Expert Insights Quiz

How does tardive dyskinesia impact medication adherence?

02/14/2023

True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.

True or false: Patients with...

02/14/2023

Psych Congress Network

Expert Insights Quiz

Which Areas of Patients' Lives Does Tardive Dyskinesia Negatively Impact?

11/22/2022

Test your clinical knowledge with this quick quiz!

Test your clinical knowledge...

11/22/2022

Psych Congress Network

Quiz

What percentage of patients taking deutetrabenazine for TD saw adverse events?

10/16/2022

Time for a pop quiz! Test your tardive dyskinesia knowledge.

Time for a pop quiz! Test your...

10/16/2022

Psych Congress Network

Quiz

Can the Semiformal Movement Disorder Assessment Replace AIMS?

07/08/2022

True or false? Clinicians can replace the AIMS assessment with the semiformal movement disorder assessment process performed more regularly at appointments with patients taking antipsychotic medication.

True or false? Clinicians can...

07/08/2022

Psych Congress Network

Quiz

Can long-term anticholinergic medication exposure cause long-term consequences?

10/28/2021

True or false: Long-term anticholinergic medication exposure can cause long-term consequences that surpass previously documented short-term cognitive effects.

True or false: Long-term...

10/28/2021

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Tardive Dyskinesia Quiz

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products